Rhabdomyolysis or Severe Acute Hepatitis Associated with the Use of Red Yeast Rice Extracts: an Update from the Adverse Event Reporting Systems
出版年份 2023 全文链接
标题
Rhabdomyolysis or Severe Acute Hepatitis Associated with the Use of Red Yeast Rice Extracts: an Update from the Adverse Event Reporting Systems
作者
关键词
-
出版物
Current Atherosclerosis Reports
Volume 25, Issue 11, Pages 879-888
出版商
Springer Science and Business Media LLC
发表日期
2023-10-13
DOI
10.1007/s11883-023-01157-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review
- (2023) Arrigo F. G. Cicero et al. Nutrients
- Statin-induced Liver Injury Patterns: A Clinical Review
- (2022) Leon D. Averbukh et al. Journal of Clinical and Translational Hepatology
- Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
- (2022) Massimiliano Ruscica et al. CARDIOVASCULAR RESEARCH
- Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis
- (2022) Masayuki Chuma et al. CLINICAL INFECTIOUS DISEASES
- Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
- (2022) Peter E. Penson et al. Journal of Cachexia Sarcopenia and Muscle
- Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel
- (2022) Maciej Banach et al. PHARMACOLOGICAL RESEARCH
- Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)
- (2022) Maciej Banach et al. Cardiovascular Diabetology
- HMG-CoA reductase inhibitors (Statins) and their Drug Interactions involving CYP enzymes, P-glycoprotein and OATP Transporters - An Overview
- (2021) Rajkapoor Balasubramanian et al. CURRENT DRUG METABOLISM
- Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia
- (2021) Maciej Banach et al. Archives of Medical Science
- Red Yeast Rice for Hypercholesterolemia
- (2021) Arrigo F.G. Cicero et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Review of Red Yeast Rice, a Traditional Fermented Food in Japan and East Asia: Its Characteristic Ingredients and Application in the Maintenance and Improvement of Health in Lipid Metabolism and the Circulatory System
- (2021) Hiroyuki Fukami et al. MOLECULES
- Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patients
- (2021) John W Davis et al. BMJ Open
- Incidence of elevated creatine phosphokinase between daptomycin alone and concomitant daptomycin and statins: A systematic review and meta‐analysis
- (2021) Masaru Samura et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Narrative Review of Statin-Induced Rhabdomyolysis: Molecular Mechanism, Risk Factors, and Management
- (2021) Nisa Safitri et al. Drug Healthcare and Patient Safety
- Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials
- (2019) Federica Fogacci et al. PHARMACOLOGICAL RESEARCH
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- A comprehensive review on biological properties of citrinin
- (2017) José Williams Gomes de Oliveira Filho et al. FOOD AND CHEMICAL TOXICOLOGY
- Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention
- (2016) Tina Heinz et al. NUTRITION RESEARCH
- Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – A systematic review and meta-analysis
- (2015) Maaike C. Gerards et al. ATHEROSCLEROSIS
- Symptomatic Hepatitis Associated with the Use of Herbal Red Yeast Rice
- (2013) Harry Roselle et al. ANNALS OF INTERNAL MEDICINE
- Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products
- (2013) Chia-Hao Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- OATP1B1-related drug–drug and drug–gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis
- (2013) Bani Tamraz et al. Pharmacogenetics and Genomics
- Drug induced rhabdomyolysis
- (2012) Martin Hohenegger CURRENT OPINION IN PHARMACOLOGY
- Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin
- (2012) Chia-Hao Chen et al. Evidence-based Complementary and Alternative Medicine
- Characteristics of Drug-Associated Rhabdomyolysis: Analysis of 8,610 Cases Reported to the U.S. Food and Drug Administration
- (2011) Yasuo Oshima INTERNAL MEDICINE
- Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
- (2011) Einar Björnsson et al. JOURNAL OF HEPATOLOGY
- Acute hepatitis caused by a natural lipid-lowering product: When “alternative” medicine is no “alternative” at all
- (2009) Antonio Grieco et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More